tiprankstipranks
Adial Pharmaceuticals Finalizes Separation Agreement with Dr. Johnson
Company Announcements

Adial Pharmaceuticals Finalizes Separation Agreement with Dr. Johnson

Adial Pharmaceuticals Inc (ADIL) just unveiled an announcement.

Adial Pharmaceuticals, Inc. has finalized a Separation Agreement with Dr. Bankole A. Johnson, entitling him to a one-time fee of $54,375 and the opportunity to earn up to $225,000 based on meeting specific milestones for AD04 development by the end of 2024. Additionally, Dr. Johnson can offer consulting services to the company at $850 per hour. The agreement also includes a clause preventing both parties from making disparaging remarks about each other.

See more data about ADIL stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAdial Pharmaceuticals announces publication on efficacy of AD04
GlobeNewswireAdial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!